Lineage Cell Therapeutics, Inc. Common Stock (LCTX)

Net Change in Cash

$1.42M

Quarterly · Period ending: · USD

LCTX logo

LCTX Net Change in Cash

Latest reported$1.42M
LCTX Quarterly Net Change in Cash (-$300.00K → $1.42M)
High-resolution chart · PNG

LCTX net change in cash history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Lineage Cell Therapeutics, Inc. Common Stock Net Change in Cash — Quarterly (USD)
Period endingNet Change in Cash (USD)
1,416,000
-4,852,000
347,000
-1,798,000
-5,567,000
1,988,000
18,048,000
-1,864,000
-13,952,000
8,130,000
3,992,000
-2,448,000
18,427,000
4,085,000
-13,361,000
-46,064,000
-7,245,000
22,329,000
-5,051,000
-1,188,000
5,800,000
23,533,000
48,000
19,891,000
2,855,000
293,000
-4,866,000
6,166,000
-9,894,000
-5,709,000
4,112,000
-7,344,000
-2,620,000
-7,434,000
20,176,000
2,112,000
-9,266,000
1,728,000
-8,363,000
2,749,000
570,000
-15,097,000
12,851,000
-2,087,000
5,635,467
-3,657,376
22,070,674
-8,305,273
9,083,674
1,142,356
-1,221,865
-7,588,953
4,409,961
5,546,368
-3,480,380
-4,829,496
-3,828,063
-5,723,991
-4,018,401
-1,151,643
-2,755,038
-3,187,945
7,903,330
7,365,505
6,883,027
-1,016,019
4,246,504
3,249,851
4,151,620
528,827
-39,803
-120,379
-135,010
297,970
-4,259
-113,482
-150,038
-283,737
-194,536
-243,883
-89,710
-744,628
1,658,210
-412,976
-123,226
-658,996
-198,083
-182,283
-368,675
1,402,619
-464,351
531,140
-73,124
-560,913
-544,707
1,327,848
-486,179
-665,278
-284,035
1,743,810
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.